Science Current Events | Science News | Brightsurf.com
 
Email a Friend Send to a friend
Printer Friendly Print Researchers discover key mechanism by which lethal viruses Ebola and Marburg cause disease

Researchers discover key mechanism by which lethal viruses Ebola and Marburg cause disease

October 17, 2006

Discovery is expected to lead to new drugs for treatment of certain viral hemorrhagic fevers in humans and apes

Researchers in the Greene Infectious Disease Laboratory at Columbia University's Mailman School of Public Health, the Centers for Disease Control and Prevention, and the Caribbean Primate Research Center have discovered a key mechanism by which the Filoviruses, Ebola and Marburg, cause disease. The identification of an amino acid sequence in Filoviruses that results in the rapid depression of immunological response is described in the December 2006 issue of The FASEB Journal. Using this information, researchers can begin to develop new drugs to stop these devastating diseases.




Filoviruses, named for their threadlike appearance in electron microscopy (filo= thread in Latin), are associated with outbreaks of fatal hemorrhagic fever in sub-Saharan Africa. Viral hemorrhagic fevers are of specific concern because they are associated with high morbidity and mortality (up to 80% mortality rates) and the potential for rapid dissemination through human-to-human transmission. The term "viral hemorrhagic fever" characterizes a severe multisystem syndrome associated with fever, shock, and bleeding caused by infection with one of a number of viruses, including the Filoviruses Ebola and Marburg.

Both humans and apes are susceptible to viral hemorrhagic fevers, and it is speculated that filovirus infections account at least in part for the recent decline in the gorilla and chimpanzee population in central Africa. There is no cure or approved vaccine for either Marburg or Ebola virus. Immunosuppression occurs early after infection and allows the viruses to reproduce rapidly and cause disease.

"Currently, there is no way to treat most viral hemorrhagic fever outbreaks, and increased international travel, trafficking in wildlife, political instability, and terrorism have made emerging infectious diseases a global concern," stated W. Ian Lipkin, MD, director of the Greene Infectious Disease Laboratory at the Mailman School's Department of Epidemiology and professor of Epidemiology, Neurology, and Pathology at Columbia University. "The identification of this new mechanism for immunosuppression is anticipated to lead to new drugs for intervention in filoviral hemorrhagic fevers of humans and apes."

In the study, researchers describe a series of amino acids in Ebola and Marburg viruses that resemble proteins in retroviruses known to suppress the immune system. By targeting these amino acids, new drugs could disrupt the ability of these viruses to shut down immune systems and make them vulnerable to the body's natural defenses.

"This brilliant study shows that many viruses, including HIV, use a similar mechanism to disarm their victims," said Gerald Weissmann, MD, Editor-in-Chief of The FASEB Journal. "The Columbia study has shown us new ways to fight against deadly viruses the world over."

The method for discovering this protein underscores the power of bioinformatics for addressing the challenges of emerging infectious diseases. The investigators are currently exploring whether insights derived from understanding the potency of these immunosuppressive peptides can be exploited to treat autoimmune diseases.

Columbia University's Mailman School of Public Health



Related Ebola Current Events and Ebola News Articles Ebola Current Events and Ebola News RSS Ebola Current Events and Ebola News RSS
1930s drug slows tumor growth
Drugs sometimes have beneficial side effects. A glaucoma treatment causes luscious eyelashes. A blood pressure drug also aids those with a rare genetic disease.

Exon-skipping drug prevents muscle wasting, maintains muscle function in dystrophin deficient mice
An exon skipping PPMO has demonstrated dramatic effects in the prevention and treatment of severely affected, dystrophin and utrophin-deficient mice, preventing severe deterioration of the treated animals and extending their lifespan.

Outfoxing pox: Developing a new class of vaccine candidates
In the annals of medicine, Edward Jenner's 1796 vaccination of a young boy against smallpox, using fluid from cowpox blisters, remains a landmark case. In a new study, Kathryn Sykes, a researcher at Arizona State University's Biodesign Institute and her colleagues have taken a fresh look at cowpox.

World will miss 2010 target to stem biodiversity loss, experts say
The world will miss its agreed target to stem biodiversity loss by next year, according to experts convening in Cape Town for a landmark conference devoted to biodiversity science.

Scientists block Ebola infection in cell-culture experiments
Researchers at the University of Texas Medical Branch at Galveston have discovered two biochemical pathways that the Ebola virus relies on to infect cells.

OHSU scientists partner with others to form center aimed at combating infectious diseases
Oregon Health & Science University and the University of Washington, along with a number of partner institutions across the Northwest, have received federal funding to form a regional research center aimed at combating emerging or re-emerging infectious diseases that pose a serious threat to human health.

Drug blocks 2 of world's deadliest emerging viruses
Two highly lethal viruses that have emerged in recent outbreaks are susceptible to chloroquine, an established drug used to prevent and treat malaria, according to a new basic science study by researchers at Weill Cornell Medical College in the Journal of Virology.

Penn Study Identifies How Ebola Virus Avoids the Immune System
Researchers at the University of Pennsylvania School of Medicine have likely found one reason why the Ebola virus is such a powerful, deadly, and effective virus. Using a cell culture model for Ebola virus infection, they have discovered that the virus disables a cellular protein called tetherin that normally can block the spread of virus from cell to cell.

Iowa State University researchers discover structure of key Ebola protein
Research led by Iowa State University scientists has them a step closer to finding a way to counter the Ebola virus.

UT Southwestern researchers develop new strategy for broad spectrum anti-viral drugs
Bavituximab, an anti-viral drug developed by UT Southwestern Medical Center researchers, shows promise as a new strategy to fight viral diseases, including potential bioterrorism agents.
More Ebola Current Events and Ebola News Articles
Ebola: Through the Eyes of the People

Ebola: Through the Eyes of the People
by William T. Close (Author)

At a Catholic Mission in Yambuku, an oasis of peace and efficiency in northern Congo's vast jungle forests, Mabalo Lokela, a teacher, receives an anti-malarial shot for a raging fever and headache. Sister Lucie, a Flemish nursing sister, swishes out a syringe with a weak disinfectant. The next patients are injected with the same syringe and the sick man's virus spreads.

Lokela was the first Congolese victim of a new African hemorrhagic disease that became known as Ebola fever. When Sister Lucie dies a few days later, panic erupts and hospitalized patients flee into the forest. With the convent connected to the outside world by a single primitive radio, the mission nuns can only pray and wonder if anyone will act on their cries for help.

NOVA: Ebola - The Plague Fighters

NOVA: Ebola - The Plague Fighters
Starring: Nova
Directed By: Nova

Enter the "hot zone" of one of the most frightful diseases on the planet- Ebola.

When a dreaded outbreak of the deadly Ebola virus swept through a remote region of Zaire in May 1995, NOVA was the only film crew permitted into the "hot zone." Spending a total of four weeks in the quarantined city of Kikwit, the result is unprecedented journalistic coverage of this grim battle against one of the world's most lethal diseases.

The Ebola plague kills a very high percentage of its victims (77% in Kikwit), often by dissolving their internal organs and connective tissue. Learn how disease specialists traced the origins of the outbreak by compiling a complete "chain of death" of the epidemic, and why they fear a mutation of Ebola will emerge that is even more difficult to contain.

Ebola

Ebola
by Dr. William Close (Author)

IT STRIKES WITHOUT WARNING--A HORRIFYING, LETHAL DISEASE WITH NO NAME. AND NO CURE. . . .

Now, from the molten center of the "hot zone," comes a terrifying, completely authentic novel of medical suspense by William T. Close, M.D., the American physician who lived in Zaire for sixteen years, and who worked desperately to contain the first outbreak of the virus in 1976. Haunted by the images from this wrenching time, and unable to forget the people he knew and lost, Dr. Close was compelled to tell their story. EBOLA, inspired by his personal experience and based upon extensive research, is an unforgettable portrait of this devastating drama, which all began with an invisible, unknown killer . . . .

EBOLA

At a Catholic mission in Yambuku, a remote area of Zaire, Mabalo Lokela, a local...

Ebola Syndrome

Ebola Syndrome
Starring: Anthony Wong Chau-Sang, Yeung Ming Wan, Fui-On Shing, Wong Tsui-ling, Miu-Ying Chan
Directed By: Herman Yau
Also With: Jing Wong (Producer), Ting Chau (Writer)


Region 1
Original Cantonese Language
Optional English Subtitles
Dolby Digital audio
16 x 9 Anamorphic Widescreen
Original 1.85:1 Aspect Ratio
Theatrical Trailer
Photo Gallery
Audio commentary with Anthony Wong and Herman Yau
Interview with the director Herman Yau
Never before seen deleted scenes!


Kai San is a sleazy and despicable bastard of the most epic proportions! After being caught screwing the wife of his boss, he goes on a killing spree and flees Hong Kong. 10 years later, Kai finds himself working as a restaurant chef in South Africa. Overworked, underpaid, berated, and extorted by the restaurant owners who know of his fugitive status, Kai is a ticking timebomb...

While visiting an ebola infected...

Emerging Viruses: AIDS And Ebola : Nature, Accident or Intentional?

Emerging Viruses: AIDS And Ebola : Nature, Accident or Intentional?
by Leonard G. Horowitz (Author)



EBOLA GIANT MICROBE PLUSH

EBOLA GIANT MICROBE PLUSH
by Giant Microbes

Since its discovery in 1976, Ebola has become the T. Rex of microbes.
Share the love!

The Hot Zone: A Terrifying True Story

The Hot Zone: A Terrifying True Story
by Richard Preston (Author)

A highly infectious, deadly virus from the central African rain forest suddenly appears in the suburbs of Washington, D.C. There is no cure. In a few days 90 percent of its victims are dead. A secret military SWAT team of soldiers and scientists is mobilized to stop the outbreak of this exotic "hot" virus. The Hot Zone tells this dramatic story, giving a hair-raising account of the
appearance of rare and lethal viruses and their "crashes" into the human race. Shocking, frightening, and impossible to ignore, The Hot Zone proves that truth really is scarier than fiction.


From the Paperback edition.

NOVA: Epidemic - Ebola, AIDS, Bird Flu and Typhoid

NOVA: Epidemic - Ebola, AIDS, Bird Flu and Typhoid
Starring: Nova
Directed By: Nova

Includes four programs: NOVA-Ebola The Plague Fighters; NOVA-Surviving AIDS, NOVA-Typhoid Mary: The Most Dangerous Woman in America; and Rx for Survival-Bird Flu.

Ebola (Deadly Diseases and Epidemics)

Ebola (Deadly Diseases and Epidemics)
by Tara C. Smith (Author)



Ebola, Culture and Politics: The Anthropology of an Emerging Disease (Case Studies on Contemporary Social Issues)

Ebola, Culture and Politics: The Anthropology of an Emerging Disease (Case Studies on Contemporary Social Issues)
by Barry S. Hewlett (Author), Bonnie L. Hewlett (Author)

In this case study, readers will embark on an improbable journey through the heart of Africa to discover how indigenous people cope with the rapid-killing Ebola virus. The Hewletts are the first anthropologists ever invited by the World Health Organization to join a medical intervention team and assist in efforts to control an Ebola outbreak. Their account addresses political, structural, psychological, and cultural factors, along with conventional intervention protocols as problematic to achieving medical objectives. They find obvious historical and cultural answers to otherwise-puzzling questions about why village people often flee, refuse to cooperate, and sometimes physically attack members of intervention teams. Perhaps surprisingly, readers will discover how some cultural practices...

© 2009 BrightSurf.com